Vladimir Novitsky

The role of CYP2B6 516G>T polymorphism on efavirenz/nevirapine toxicity. Implications on treatment outcomes: Lessons from Botswana.

Maseng MJ, Tawe L, Thami PK, Moyo S, Kasvosve I, Novitsky V, Essex M, Russo G, Gaseitsiwe S, Paganotti GM.

Medicine (Baltimore). 2022 Apr 29. 101(17):e29066. PMID: 35512066

HIV-1 drug resistance mutations among individuals with low-level viraemia while taking combination ART in Botswana.

Bareng OT, Moyo S, Zahralban-Steele M, Maruapula D, Ditlhako T, Mokaleng B, Mokgethi P, Choga WT, Moraka NO, Pretorius-Holme M, Mine MO, Raizes E, Molebatsi K, Motswaledi MS, Gobe I, Mohammed T, Gaolathe T, Shapiro R, Mmalane M, Makhema JM, Lockman S, Essex M, Novitsky V, Gaseitsiwe S.

J Antimicrob Chemother. 2022 04 27. 77(5):1385-1395. PMID: 35229102

Human Immunodeficiency Virus (HIV) Genetic Diversity Informs Stage of HIV-1 Infection Among Patients Receiving Antiretroviral Therapy in Botswana.

Ragonnet-Cronin M, Golubchik T, Moyo S, Fraser C, Essex M, Novitsky V, Volz E.

J Infect Dis. 2022 04 19. 225(8):1330-1338. PMID: 34077517

Real-Life Feasibility of HIV Drug Resistance Testing Using Dried Filter Analytes in Kenyan Children and Adolescents Living with HIV.

Manne A, DeLong A, Nyandiko W, DeLong AK, Vreeman R, Novitsky V, Ngeresa A, Sang E, Chory A, Aluoch J, Jepkemboi E, Orido M, Ashimosi C, Sang F, Hogan JW, Kantor R.

Microbiol Spectr. 2022 04 27. 10(2):e0267521. PMID: 35389242

Deep-sequence phylogenetics to quantify patterns of HIV transmission in the context of a universal testing and treatment trial - BCPP/Ya Tsie trial.

Magosi LE, Zhang Y, Golubchik T, DeGruttola V, Tchetgen Tchetgen E, Novitsky V, Moore J, Bachanas P, Segolodi T, Lebelonyane R, Pretorius Holme M, Moyo S, Makhema J, Lockman S, Fraser C, Essex MM, Lipsitch M.

Elife. 2022 03 01. 11. PMID: 35229714

HIV-1 Treatment Failure, Drug Resistance, and Clinical Outcomes in Perinatally Infected Children and Adolescents Failing First-Line Antiretroviral Therapy in Western Kenya.

Nyandiko W, Holland S, Vreeman R, DeLong AK, Manne A, Novitsky V, Sang F, Ashimosi C, Ngeresa A, Chory A, Aluoch J, Orido M, Jepkemboi E, Sam SS, Caliendo AM, Ayaya S, Hogan JW, Kantor R.

J Acquir Immune Defic Syndr. 2022 02 01. 89(2):231-239. PMID: 34723922

Genome-wide association study reveals genetic variants associated with HIV-1C infection in a Botswana study population.

Shevchenko AK, Zhernakova DV, Malov SV, Komissarov A, Kolchanova SM, Tamazian G, Antonik A, Cherkasov N, Kliver S, Turenko A, Rotkevich M, Evsyukov I, Vlahov D, Thami PK, Gaseitsiwe S, Novitsky V, Essex M, O'Brien SJ.

Proc Natl Acad Sci U S A. 2021 11 23. 118(47). PMID: 34782459

Limited HIV-1 Subtype C nef 3'PPT Variation in Combination Antiretroviral Therapy Naïve and Experienced People Living with HIV in Botswana.

Seatla KK, Maruapula D, Choga WT, Morerinyane O, Lockman S, Novitsky V, Kasvosve I, Moyo S, Gaseitsiwe S.

Pathogens. 2021 Aug 13. 10(8). PMID: 34451492

HIV Drug Resistance and Transmission Networks Among a Justice-Involved Population at the Time of Community Reentry in Washington, D.C.

Beckwith CG, Min S, Manne A, Novitsky V, Howison M, Liu T, Kuo I, Kurth A, Bazerman L, Agopian A, Kantor R.

AIDS Res Hum Retroviruses. 2021 12. 37(12):903-912. PMID: 33896212

Association of CYP2B6 Genetic Variation with Efavirenz and Nevirapine Drug Resistance in HIV-1 Patients from Botswana.

Maseng MJ, Tawe L, Thami PK, Seatla KK, Moyo S, Martinelli A, Kasvosve I, Novitsky V, Essex M, Russo G, Gaseitsiwe S, Paganotti GM.

Pharmgenomics Pers Med. 2021. 14:335-347. PMID: 33758532